What is TrichoTest?
TrichoTest is a commercial pharmacogenetic test designed to help clinicians personalise treatment for hair loss. A DNA sample is collected with a cheek swab, genetic variants are analysed, and the results are combined with information about your medical history to generate treatment suggestions.
The idea is reasonable: people do not respond identically to minoxidil, finasteride and other hair-loss treatments, and part of that variation is biological. The important question is not whether genetics matter — they do — but how accurately a commercial test can turn those genetic differences into a better treatment decision for one individual.
Does TrichoTest diagnose the cause of my hair loss?
No. A genetic test should not replace diagnosis.
Hair loss can be caused by androgenetic alopecia, telogen effluvium, alopecia areata, traction, medication, nutritional problems, thyroid disease, scalp inflammation or a scarring alopecia. These conditions are not interchangeable, and they need different treatment.
A proper assessment still starts with your history and scalp examination. Trichoscopy is often useful, particularly in women with pattern hair loss. Blood tests may be appropriate when the history suggests iron deficiency, thyroid disease, hormonal abnormalities or another systemic cause.
If a clinic offers genetic testing before establishing what type of hair loss you have, the order is backwards.
What does the test actually look for?
TrichoTest analyses selected genetic variants related to pathways involved in hair biology and treatment response. The commercial report then links those findings to possible topical, oral or injectable treatment options.
This is different from a diagnostic genetic test for a rare inherited disorder. Most common pattern hair loss is polygenic: many genetic variants contribute small effects, together with age, hormones and other biological factors.
Modern genomic studies have identified hundreds of loci associated with androgenetic alopecia. That makes the genetics scientifically interesting, but it also means there is no single “hair-loss gene” that tells a doctor exactly which treatment will work.
Can genes predict whether minoxidil or finasteride will work for me?
Possibly to some extent, but the science is not yet strong enough to make treatment response perfectly predictable.
Research has linked sulfotransferase activity and variants involving the SULT1A1 pathway to minoxidil response. Other studies have explored androgen-receptor variants and response to finasteride. These findings support the broader concept of pharmacogenetics in hair loss.
However, promising associations are not the same as a clinically validated prediction tool. Small studies can find correlations that later prove weaker in larger or more diverse populations. A 2026 review of the genetic landscape of androgenetic alopecia concluded that pharmacogenetic findings are developing, but no genetic markers are yet validated for routine clinical decision-making.
How reliable is the TrichoTest treatment recommendation?
This is where expectations need to be realistic.
The laboratory can identify the genetic variants it tests for with high technical accuracy. That is not the same thing as proving that the final treatment recommendation is clinically accurate.
In our PubMed search, we found substantial research on the genetics of androgenetic alopecia and on individual markers that may influence treatment response. We did not find strong independent prospective trials showing that patients treated according to the commercial TrichoTest algorithm achieve better outcomes than patients managed using standard dermatologic assessment and evidence-based treatment.
That does not mean the test has no value. It means the evidence for the algorithm as a decision tool is less established than the marketing language around personalised medicine may suggest.
Does my ancestry matter when interpreting a genetic hair-loss test?
Yes. Genetic associations do not always transfer equally between populations.
A 2025 study of more than 2,000 African men found that polygenic baldness scores developed mainly from European datasets performed poorly in African populations. This is an important limitation for any genetic prediction system: a variant can be biologically relevant without having the same predictive value across different ancestries.
Women are also underrepresented in some genetic datasets, and female-pattern hair loss is biologically less well defined than classic male androgenetic alopecia.
When might TrichoTest be useful?
It may be most useful as additional information when the diagnosis is already clear and treatment selection is genuinely uncertain — for example, after an inadequate response or poor tolerance to standard options.
It may also appeal to someone who wants a more personalised discussion before committing to long-term medication. In that setting, the report can provide topics for a clinician to consider rather than acting as an automatic prescription.
What it should not do is override contraindications, pregnancy considerations, drug interactions, side-effect history or the clinical diagnosis.
What can TrichoTest not tell me?
- It cannot tell you with certainty whether you will regrow hair.
- It cannot determine how much hair you will regain or how quickly.
- It cannot replace scalp examination or trichoscopy.
- It cannot rule out iron deficiency, thyroid disease or other medical causes of shedding.
- It cannot reliably predict the future progression of your hair loss from genetics alone.
- It does not turn a treatment with weak clinical evidence into a proven treatment simply because your report ranks it favourably.
If I do the test once, will the result stay valid?
Your DNA does not change, so the raw genetic variants do not need to be retested. But the interpretation can change as research evolves.
This distinction matters. A “once-in-a-lifetime” DNA sample does not mean that today's treatment algorithm will remain the best interpretation of those genes forever. New drugs, larger genetic studies and better pharmacogenetic evidence can change what a result means clinically.
What should I ask before paying for a genetic hair-loss test?
- Has my type of hair loss actually been diagnosed?
- Who will interpret the report — a dermatologist, hair-loss physician or salesperson?
- Will the recommendation change management compared with standard treatment?
- What evidence supports the specific treatment suggested for my genetic result?
- Are the recommended medicines approved for this use, off-label, or compounded?
- What happens if the genetic recommendation conflicts with my medical history or contraindications?
TrichoTest can be an interesting additional tool. It is not a shortcut around diagnosis, and it should not create false precision where the science is still developing.
